Researcher.Life Logo

Transplantation and Cellular Therapy : Impact Factor & More

eISSN: 2666-6367pISSN: 2666-6375

Key Metrics

CiteScore
7.8
Impact Factor
< 5
Scite Index
0.84 5-Year SI
SJR
Q2Hematology
SNIP
1.44
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Transplantation and Cellular Therapy

Transplantation and Cellular Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER SCIENCE INC
Frequency Monthly
General Details
FrequencyMonthly
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Transplantation and Cellular Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Transplantation and Cellular Therapy

Cytomegalovirus Interstitial Pneumonia: A Plague of Marrow Transplant That the Field Solved.
  • 1 Jul 2026
  • Transplantation and cellular therapy
Rectal Colonization with Multidrug-Resistant Organisms and Subsequent Bloodstream Infections in Hematological Patients Undergoing Cellular Therapies.
  • 1 Jul 2026
  • Transplantation and cellular therapy
Do We Sin When Treating Patients with Higher-Risk Myelodysplastic Syndromes?
  • 1 Jul 2026
  • Transplantation and cellular therapy
Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.
  • 1 Jul 2026
  • Transplantation and cellular therapy
Simplification of Hematopoietic Stem Cell Transplantation and Continued FACT Accreditation: Strategies for Low- and Middle-Income Countries.
  • 1 Jul 2026
  • Transplantation and cellular therapy
The Last Mile in CAR-T Cell Therapy.
  • 1 Jul 2026
  • Transplantation and cellular therapy
Cytomegalovirus Interstitial Pneumonia: A Plague of Marrow Transplant That the Field Solved.
  • 1 Jul 2026
  • Transplantation and cellular therapy
Rectal Colonization with Multidrug-Resistant Organisms and Subsequent Bloodstream Infections in Hematological Patients Undergoing Cellular Therapies.
  • 1 Jul 2026
  • Transplantation and cellular therapy
Do We Sin When Treating Patients with Higher-Risk Myelodysplastic Syndromes?
  • 1 Jul 2026
  • Transplantation and cellular therapy
Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.
  • 1 Jul 2026
  • Transplantation and cellular therapy
Simplification of Hematopoietic Stem Cell Transplantation and Continued FACT Accreditation: Strategies for Low- and Middle-Income Countries.
  • 1 Jul 2026
  • Transplantation and cellular therapy
The Last Mile in CAR-T Cell Therapy.
  • 1 Jul 2026
  • Transplantation and cellular therapy

FAQs on Transplantation and Cellular Therapy